A CE/kininase II inhibitors improve insulin sensitivity (1-7). This action of ACE inhibitors is mediated in part by bradykinin (BK), a peptide known to enhance GLUT4 translocation (8-10). Skeletal muscle, making up 25-45% of the body weight in humans, represents the largest target for insulin. In this tissue, insulin binds to insulin receptors on the cell membrane and promotes phosphorylation of the -subunit of the recept o r, a process that, in turn, results in phosphorylation of the intracellular insulin receptor substrate (IRS)-1 on tyrosine residues and activation of phosphatidylinositol (PI) 3-kinase (11). Activation of PI 3-kinase is an important step in the translocation of GLUT4 in skeletal muscle (11).
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Several components of the kallikrein-kinin system have been identified in skeletal muscle. A tissue kallikrein, an enzyme responsible for the formation of kinins, has been isolated and purified from and quantitated in rat skeletal muscle (12). BK is released from skeletal muscle during brief static contractions of relatively high intensity (13). We recently reported that BK B 2 receptors are present in skeletal muscle and that stimulation of these receptors results in activation of a phosphoinositide-specific phospholipase C (PLC) and a transient increase in the formation of inositol 1,4,5-trisphosphate (IP 3 ) (14,15). In skeletal muscle, IP 3 m a y not only participate in the physiological regulation of excitation-contraction coupling (16-18), but could also play a role in the pathophysiology of muscle diseases such as malignant hyperthermia (19-21) and exertional rhabdomyolysis (22,23).
The aim of the present study was to investigate whether insulin interacts with the signaling from the BK receptor to modulate BK-induced IP 3 formation in L8 rat skeletal myoblasts. Because several peptides, including BK (24) and insulin (25), induce tyrosine phosphorylation of proteins in cultured cells and intact animals, we investigated whether a tyrosine kinase participates in the regulation of BK-induced I P 3 formation by insulin. Because PI 3-kinase is one of the key signal transducers in insulin-stimulated glucose uptake, we also studied whether insulin-stimulated PI 3-kinase mediates the effect of insulin on BK-induced IP 3 formation. In addition, we also examined whether intracellular calcium or calmodulin modulate this combined action of insulin and BK.
RESEARCH DESIGN AND METHODS
Cell culture and incubations. Monolayers of L8 rat skeletal myoblasts were grown for 4 days in a mixture of M199 and Dulbecco's modified Eagle's medium in a 1:4 ratio, containing antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin, and 50 µg/ml gentamicin) and supplemented with 10% horse serum. Cells were grown on 0.1% gelatin-coated 25 c m 2 flasks (Costar, Cambridge, MA) in an atmosphere of 5% CO 2 /95% air at 37°C. At 24 h before the experiments, the nearly confluent cells were incubated in serum-depleted medium.
Cultures were incubated with one of the following reagents: wortmannin (an inhibitor of PI 3-kinases), 3,4,5-trimethoxybenzoic acid 8-[diethylamino]octyl ester (TMB-8) (a calcium antagonist), n-[ 6 -a m i n o h e x y l ] -5 -c h l o r o -1 -n a p h t h a l e n esulfonamide (W-7) (a calmodulin antagonist), or the vehicle for 120 min and with insulin or the vehicle for the last 90 min before adding BK. Incubations with genistein, tyrphostin A-23 (two tyrosine kinase inhibitors), or the vehicle were done for 130 min and with insulin or the vehicle for the last 120 min before adding BK. I P 3 m e a s u r e m e n t . After the serum-depleted L8 cells were incubated with BK for 15 s, the reaction was stopped by the addition of 0.2 ml ice-cold 100% trichloroacetic acid (TCA) for each 1 ml of culture medium. The acid extract was homogenized at 0-4°C, incubated for 15 min on ice, centrifuged for 30 min at 2,000g, and the pellet was discarded. TCA was removed from the extracts by adding 2 ml of a mixture of 3 volumes of 1,1,2-trichloro-1,2,2-trifluoroethane plus 1 volume of trioctylamine for each 1 ml of TCA extract.
I P 3 content in the aqueous top layer was determined by using a radioreceptor assay kit from NEN Research Products-Du Pont (Boston, MA). Protein measurements. Protein was determined by the method of Bradford with bovine serum albumin as standard (26). Drugs and solutions. L8 rat skeletal myoblasts were obtained from the American Type Culture Collection (Rockville, MD). TMB-8, W-7, and wortmannin (from Penicillium fumiculosum) were purchased from Sigma (St. Louis, MO). Genistein and tyrphostins A1 and A23 were purchased from Calbiochem (San Diego, CA) and dissolved in 0.5% DMSO and kept protected from light. The final concentration of this solvent in the culture flasks was <0.005%. Wortmannin was dissolved in 0.1% dimethylsulfoxide and was added to the culture medium in <10 µl volume. All other drugs were dissolved in water and added to the culture medium in <100 µl volume. Statistical analysis. Results are expressed as means ± SE. Each experiment was carried out in duplicate. Every experiment was repeated six times with different cell preparations. The significance of the differences was determined with analysis of variance. When a significant F value was obtained, comparisons of mean values were done with the Student's t test for paired and unpaired samples, the Bonferroni test, and the Student-Newman-Keuls multiple comparison test. A P < 0.05 was considered statistically signific a n t .
R E S U LT S
Stimulation of L8 rat skeletal myoblasts with BK (10 nmol/l) for 15 s increased IP 3 formation from a basal level of 75.2 ± 7.6 to 200.2 ± 15.7 pmol/mg protein (Fig. 1) . Treatment of the cultures with 1, 2, and 20 nmol/l of insulin for 90 min before adding BK increased the IP 3 response to the same BK dose to 328.2 ± 19, 434.5 ± 18, and 460.8 ± 21.3 pmol/mg protein, respectively ( F i g . 1). Insulin alone did not increase IP 3 formation; this required stimulation of the BK receptor by the ligand.
We investigated the effect of wortmannin, a PI 3-kinase antagonist, on BK-induced IP 3 production in combination with various concentrations of insulin. Wortmannin at 1 0 nmol/l had no effect on IP 3 production during basal conditions or after BK was added. However, it signific a n t l y increased IP 3 formation in response to BK in the presence of insulin (Figs. 2 and 3) . At a higher concentration (100 n m o l / l ) , wortmannin significantly enhanced the BK-induced IP 3 f o rmation by itself, without insulin (Fig. 3 ) .
To study the effect of tyrosine kinase inhibition on the potentiation of BK-induced IP 3 formation by insulin, genistein or tyrphostin A23 were added to the cultures 10 min before the addition of buffer or insulin (2 nmol/ml). The cultures were then incubated for 120 min at 37°C. At 1 nmol/l concentration, both genistein and tyrphostin A23, highly selective tyrosine kinase inhibitors, completely reversed the potentiation of IP 3 formation by insulin (Figs. 4 and 5) . The IP 3 response to 10 nmol/l BK was 223.3 ± 11.8 pmol/mg protein in the absence of insulin and 402.2 ± 12.0 pmol/mg protein in the presence of 2 nmol/l insulin. However, when the cultures were exposed to 1 nmol/l genistein or tyrphostin A23, the IP 3 response to BK in the presence of insulin was 211.8 ± 46.7 and 187.7 ± 19.9 pmol/mg protein, values not significantly different from the response to BK alone. On the other hand, at a higher concentration (1 µmol/l), genistein or tyrphostin A23 appear to have nonspecific effects, since both potentiated the 
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basal IP 3 release and the BK-induced IP 3 formation without affecting the action of insulin (Figs. 4 and 5) . Tyrphostin A1, the inactive analog, had no significant effect on the level of I P 3 in response to BK plus insulin. In the presence of 1 n m o l / l tyrphostin A1, BK increased IP 3 formation from 95.2 ± 5.6 to 236.8 ± 9.9 pmol/mg protein, and insulin (2 nmol/l) potentiated the effect of BK to 401.8 ± 10.6 pmol/mg protein. Increasing the concentration of tyrphostin A1 to 1 µmol/l yielded similar results. BK increased IP 3 formation from 144.2 ± 12 to 3 5 2 . 7 ± 17.8 pmol/mg protein, and insulin (2 nmol/l) potentiated the effect of BK to 425 ± 12.7 pmol/mg protein.
BK acts through Ca 2 + -dependent mechanisms, and many C a 2 + -mediated events require the formation of Ca 2 + -c a l m o dulin complexes (27). Likewise, Ca 2 + and calmodulin participate in the molecular mechanism whereby binding of insulin to its receptor is coupled to changes in cellular metabolism (28,29). To determine whether intracellular Ca 2 + and calmodulin are involved in the potentiation of BK-induced IP 3 f o rmation by insulin, we studied the effect of TMB-8, an intracellular Ca 2 + antagonist, and W-7, a calmodulin blocker. Treatment of the cultures with TMB-8 (1 µmol/l) did not affect the IP 3 response to BK alone or in combination with insulin. In the presence of this inhibitor, IP 3 f o r m a t i o n increased from 75.2 ± 8 to 244.8 ± 18 pmol/mg protein after BK alone and to 371.5 ± 16.5, 477 ± 18, and 488 ± 16 p m o l / m g protein after BK in combination with 1, 2, and 20 n m o l / l insulin, respectively. In contrast, W-7 (0.1 µmol/l), which by itself had no effect on basal or BK-induced IP 3 f o r m a t i o n , s i g n i ficantly increased the IP 3 response to BK in the presence of 1, 2, and 20 nmol/l insulin to 488 ± 22.2, 625.5 ± 11.6, and 665.2 ± 15.9 pmol/mg protein, respectively (Fig. 6 ) .
D I S C U S S I O N
In the current study, we have found that when L8 rat skeletal myoblasts are stimulated with BK in the presence of insulin, there is an increase in IP 3 formation to a level significantly higher than that obtained after BK alone. This potentiating action of insulin takes place only after stimulation of the BK receptor by the ligand, because insulin alone does not increase IP 3 formation. Similar results were obtained in Swiss 3T3 cells stimulated by insulin and bombesin, a peptide that, like BK, acts on a G-protein-coupled receptor (30). In these cells, bombesin produced a rapid increase in IP 3 , and Several enzymes are involved in phosphoinositide metabolism, including PLC, PI kinases, tyrosine kinases, and phosphatases. Activation of PLC mediated by G-proteins generates two second messengers: 1) diacylglycerol, which activates protein kinase C; and 2) IP 3 , which can mobilize intracellular calcium (32) . In addition, direct binding of the PLC-i s oform to some autophosphorylated protein tyrosine kinase receptors, such as the insulin receptor, can lead to the generation of the same two second messengers (33) .
Transduction of the insulin signaling begins with the binding of insulin to the -subunit of the receptor and activation of the protein tyrosine kinase associated with the -s u b u n i t , which then phosphorylates itself at multiple tyrosine residues. When this occurs, IRS-1 and IRS-2 interact with the -subunit and are then phosphorylated by the receptor at many tyrosine residues. This allows these substrates to interact with and recruit to the plasma membrane the enzyme PI 3-kinase, which plays an essential role in mediating nearly all the metabolic actions of insulin. In the present work, we found that the inhibition of PI 3-kinase with wortmannin, the fungal metabolite that irreversibly binds to the p110 catalytic subunit of PI 3-kinase and inhibits its serine kinase and lipid kinase activity (34) , potentiated IP 3 formation after either BK alone (at 100 nmol/l wortmannin) or BK plus insulin (at 1 nmol/l wortmannin). Of the three forms of PI kinase (type I, II, and III), type I phosphorylates the D-3 position of the inositol ring, whereas types II and III phosphorylate the D-4 position (35) . The three phosphoinositide products of the type I kinase [PI(3)P, PI(3,4)P 2 , and PI(3,4,5)P 3 ] appear to be resistant to cleavage by PLC (36, 37) . Thus, when PI 3-kinase is inhibited, the pathway leading to the formation of phosphoinositides phosphorylated in position D-3 of the inositol ring is blocked and more substrate is available for IP 3 formation by PLC in response to BK (38) .
In our study, insulin appears to potentiate the action of BK on IP 3 formation via activation of a tyrosine kinase, because this action of insulin was inhibited by genistein and tyrphostin. Tyrosine kinases modulate inositol phosphate formation and signaling. For example, BK and bombesin rapidly stimulate tyrosine phosphorylation of a 120-kDa group of proteins in Swiss 3T3 fibroblasts (39) . In these cells, genistein appears to have a biphasic effect on the BK-promoted increase in inositol phosphate formation. At 10 µmol/l, genistein partially inhibited BK stimulation of inositol phosphate formation, whereas at 100 µmol/l genistein, the response to BK returned toward the control level. In r a s-transformed NIH/3T3 fibroblasts, the signals from the B 2 BK receptor leading to Ca 2 + i n flux follow two pathways that can be blocked with tyrosine kinase inhibitors (40) . One pathway is via the r a s-mitogen-activated protein kinase cascade and the other is via the PLC pathway that produces inositol 1,3,4,5-tetrakisphosphate (IP 4 ). Because the intracellular application of IP 3 did not affect Ca 2 + i n flux, the tyrosine phosphorylation related to PLC/phosphoinositides is located downstream of IP 4 formation, a site unlikely to be the place of action of insulin to enhance IP 3 formation in response to BK. The fact that two structurally distinct tyrosine kinase inhibitors blocked the effect of insulin on BK-stimulated IP 3 f o rmation, while an inactive analog of tyrphostins (tyrphostin A1) did not, strongly suggests that tyrosine kinases mediate this novel action of insulin.
Termination of the IP 3 signal occurs either by the IP 3 3-kinase, which adds a phosphate to the inositol ring forming I P 4 , or by the action of the polyphosphate 5-phosphatase, which removes a phosphate from the inositol ring producing inositol 1,4-bisphosphate (41) . The activity of IP 3 3-kinase is regulated by calcium-calmodulin (42) (43) (44) , enzyme phosphorylation (45) , and by altering mRNA expression (46) . In this s t u d y, we assessed the contribution of intracellular Ca 2 + a n d calmodulin to the potentiation of BK-induced IP 3 f o r m a t i o n by insulin because of the existing evidence that both Ca 2 + a n d calmodulin are spatially and functionally linked to the molecular events that occur upon the binding of insulin to its receptor (28,29). The lack of changes in the levels of IP 3 that are attained after insulin and BK in cultures that were treated with TMB-8, an intracellular Ca 2 + antagonist (47) , suggests that the action of insulin on BK-stimulated IP 3 formation does not depend on increases in intracellular Ca 2 + . However, when the cultures were treated with the calmodulin antagonist W-7, the action of insulin was significantly augmented. It is interesting to propose that calmodulin could be part of a negative feedback mechanism that controls the action of insulin on the IP 3 response to BK. On the other hand, inhibition by insulin of the metabolism of IP 3 by a polyphosphoinositide 5 -phosphatase is a possibility that needs to be explored, although insulin appears to rather stimulate polyphosphoinositide 5 -phosphatases (48) .
In summary, although insulin does not increase IP 3 f o r m ation per se, it significantly potentiates the IP 3 production in response to BK. Inhibition of PI 3-kinase potentiated IP 3 f o rmation in the presence of insulin. A tyrosine kinase with high affinity for the inhibitors genistein and tyrphostin appears to mediate the potentiation of BK-induced IP 3 f o rmation by insulin. Calmodulin has a negative effect on the action of insulin on BK-induced IP 3 formation. Ta k e n t o g e t h e r, these results provide evidence for a modulatory action of insulin on the signal transduction initiated by BK in 
